A Post-Authorization Safety Surveillance Study to Report Clinical Experience with Purified Factor IX Concentrate in Pediatric Patients with Hemophilia B.
Zoran R IgrutinovicHélène Louise HooimeijerKarim KentoucheJaco BothaPeter L TurecekMarta Kokot-KierepaHanna T GazdaPublished in: Journal of blood medicine (2024)
No treatment-related AEs were reported, and purified FIX concentrate was shown to be effective in treating and preventing bleeding episodes in pediatric patients ≤6 years old with hemophilia B.
Keyphrases